Skip to main content
. Author manuscript; available in PMC: 2010 Nov 5.
Published in final edited form as: Hypertension. 2010 Mar 19;55(6):1331–1338. doi: 10.1161/HYPERTENSIONAHA.109.146795

Table 4.

Mediators of Neurocognitive Change in EFML and Psychomotor Speed

Mediator ΔNeurocognitive Performance Adjustment for Mediator DASH+WM vs UC DASH+WM Sobel Test DASH-A vs UC DASH-A Sobel Test
EFML
 Δ weight, kg −0.30 Unadjusted 0.35* § §
Adjusted 0.46* Z101= −0.62
 Δ peak V̇ O2, mL/kg per min 0.19** Unadjusted 0.35* § §
Adjusted 0.10 Z101=2.14
 ΔSBP, mm Hg −0.16 Unadjusted 0.35* § §
Adjusted 0.26 Z101=1.53
Psychomotor speed
 Δweight, kg −0.36 Unadjusted 0.26 0.23 Z101=0.944
Adjusted −0.09 Z101=2.21 0.20
 Δpeak V̇O2, mL/kg per min 0.13 Unadjusted 0.26 0.23 Z101=0.72
Adjusted 0.10 Z101=1.72 0.21
 ΔSBP, mm Hg −0.04 Unadjusted 0.26 0.23 Z101=−0.13
Adjusted § Z101=−0.13 0.23

Contrasts are adjusted for pretreatment neurocognitive performance, age, education, IMT, Framingham Stroke Risk Profile, and abdominal adiposity.

*

P<0.01.

P<0.05.

P<0.10.

§

Data show mediation analyses that were not conducted because either there was no main effect of treatment or changes in the mediating variable were not significantly related to neurocognitive outcomes.